Europe PMC
metadata only
CC BY 4.0
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Progress in Protein Nanoparticle Vaccines for Human Viral Diseases.#455235
- A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults#28409
- BROADLY NEUTRALIZING ANTIBODIES AGAINST PANDEMIC PATHOGENS: LESSONS FOR VACCINE AND THERAPEUTIC DESIGN#929319
- Exploring the Vaccine Adjuvant Effect and Mechanism of Epimedium Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations.#232280
- Advancements in protein nanoparticle vaccine platforms to combat infectious disease#491859
Record · ID 485383
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive